Kullberg, M.C., Hay, V.H., Cheever, A.W., Mamura, M., Sher, A., Letterio, J.J., Shevach, E.M. and Piccirillo, C.A. (2005) TGF-߱ production by CD4+CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. European Journal of Immunology, 35 (10). pp. 2886-2895. ISSN 0014-2980
Naturally occurring CD4+CD25+ regulatory T cells (Treg) are potent suppressors of CD4+ and CD8+ T cell responses in vitro and inhibit several organ-specific autoimmune diseases. While most in vitro studies suggest that CD4+CD25+ Treg cells adopt a cytokine-independent but cell contact-dependent mode of T cell regulation, their precise mechanism of suppression in vivo remains largely unknown. Here we examine the functional contribution of Treg cell-derived TGF-1 and effector T cell responsiveness to TGF- in CD4+CD25+ T cell-mediated suppression of inflammatory bowel disease (IBD). We show that CD4+CD25+ Treg cells from either TGF-1+/+ or neonatal TGF-1-/- mice can suppress the incidence and severity of IBD as well as colonic IFN- mRNA expression induced by WT CD4+CD25- effector T cells. Furthermore, TGF--resistant Smad3-/- CD4+CD25+ Treg cells are equivalent to WT Treg cells in their capacity to suppress disease induced by either WT or Smad3-/- CD4+CD25- effector T cells. Finally, anti-TGF- treatment exacerbates the colitogenic potential of CD4+CD25- effector T cells in the absence of CD4+CD25+ Treg cells. Together, these data demonstrate that in certain situations CD4+CD25+ T cells are able to suppress intestinal inflammation by a mechanism not requiring Treg cell-derived TGF-1 or effector T cell/Treg cell responsiveness to TGF- via Smad3.
|Institution:||The University of York|
|Academic Units:||The University of York > Hull York Medical School (York)|
|Depositing User:||York RAE Import|
|Date Deposited:||25 May 2009 14:45|
|Last Modified:||25 May 2009 14:45|
|Publisher:||John Wiley & Sons, Ltd|